Unknown

Dataset Information

0

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.


ABSTRACT: Multiple myeloma (MM) is a plasma cells neoplasm. The overexpression of Bcl-2 family proteins, particularly myeloid cell leukemia 1 (Mcl-1), plays a critical role in the pathogenesis of MM. The overexpression of Mcl-1 is associated with drug resistance and overall poor prognosis of MM. Thus, inhibition of the Mcl-1 protein considered as a therapeutic strategy to kill the myeloma cells. Over the last decade, the development of selective Mcl-1 inhibitors has seen remarkable advancement. This review presents the critical role of Mcl-1 in the progression of MM, the most prominent BH3 mimetic and semi-BH3 mimetic that selectively inhibit Mcl-1, and could be used as single agent or combined with existing therapies.

SUBMITTER: Al-Odat O 

PROVIDER: S-EPMC8327170 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8270664 | biostudies-literature
| S-EPMC4970534 | biostudies-literature
| S-EPMC3942309 | biostudies-literature
| S-EPMC4168346 | biostudies-literature
| S-EPMC6929383 | biostudies-literature
| S-EPMC7930201 | biostudies-literature
| S-EPMC9562683 | biostudies-literature
| S-EPMC8497505 | biostudies-literature
| S-EPMC4496373 | biostudies-literature
| S-EPMC11003618 | biostudies-literature